AzTrials
AzTrials

Bone LossAcetalResinNCT07666763

Influence of Acetal Resin Versus Nylon Elastic Cap on Crestal Bone Loss in Mandibular Implant-Supported Overdenture

A study testing Acetal Resin and nylon in people with Bone Loss and Pocket, Periodontal, run by Future University in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

Objective: To evaluate and compare the effect of two different attachment housing materials-Acetal Resin (Polyoxymethylene) versus conventional Nylon elastic caps-on marginal crestal bone loss around dental implants supporting a mandibular overdenture. Read more about this study

Who is it for?
Ages 40 to 60 years, men onlyHealthy volunteers can take part
Conditions the study is for
Bone Loss, Pocket, Periodontal
What is being tested?
Acetal Resin and nylon
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
No sites listed yet
Study dates
1 Jul 2026to 1 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Completely edentulous mandible.
  • Sufficient bone height/width in mandibular residual ridges.
  • Angles classification class I.
  • Sufficient inter-arch distance

Who cannot join

  • TMJ disorders.
  • Diabetic
  • Hypertensive
  • Cancer patients.
  • Smoker
  • Osteoporosis.
  • Immunosuppressive disease
  • Any disease affecting bone/implant stability.

About this study

Objective: To evaluate and compare the effect of two different attachment housing materials-Acetal Resin (Polyoxymethylene) versus conventional Nylon elastic caps-on marginal crestal bone loss around dental implants supporting a mandibular overdenture. It also evaluates peri-implant clinical tissue health by measuring pocket depth and the gingival bleeding index.

Read the detailed description

Study Design \& Timeline: A prospective, double-blind, randomized controlled clinical trial with a 1:1 allocation ratio. Clinical and radiographic outcomes will be evaluated at overdenture insertion (baseline), and at 6 and 12 months post-insertion.ethodology \& Analysis: Pre-operative bone volume will be assessed via Cone Beam CT (CBCT). Crestal bone loss will be measured using the long cone parallel radiographic technique , while pocket depth and gingival bleeding will be measured using a William's graduated probing device. Data will undergo normality testing to determine the use of parametric (Independent t-test, Repeated Measures ANOVA) or non-parametric (Mann-Whitney, Friedman) statistical analyse

Being tested
Acetal Resin, nylon
Medical subject headings
Bone Diseases, Metabolic, Periodontal Pocket

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acetal ResinDevice

    overdenture supported by implants

  • nylonDevice

    overdenture supported by implants

Study groups in NCT07666763
Study groupRoleWhat they receive
interventionExperimentalacetal
Receives: Device: Acetal Resin
controlActive comparatorNylon Elastic
Receives: Device: nylon

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in crestal bone levels

    mm

    Measured: one year

Secondary outcomes (1)
  1. pocket depth changes

    mm

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2026
  2. Study start1 Jul 2026 (estimated)
  3. Primary completion1 Jun 2027 (estimated)
  4. Study completion1 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
22 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07666763
Sponsor's protocol ID
FUE
Acronym
AcetalResin
Status last verified
Jun 2026
First submitted
7 Jun 2026
Last updated
24 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: 1\. Chronological Timeline and FrameworkTrial Duration: The active comparative clinical trial is designed to span a duration of one year. Measurement Intervals: Data collection and patient evaluation are scheduled at three distinct time points: at overdenture insertion (baseline), at 6 months, and at 12 months post-insertion

Questions about this trial

What is this clinical trial studying?

A study testing Acetal Resin and nylon in people with Bone Loss and Pocket, Periodontal, run by Future University in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in crestal bone levels (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in